Congenica
Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. They drive precision medicine by delivering automated analysis, diagnosis, and treatment solutions to healthcare providers and patients worldwide. Their platform supports all areas of human disease where genomic information is key, including inherited diseases, cancer, pathogen surveillance, and more. Congenica's products combine state-of-the-art technology, automation, and AI to enable rapid, accurate, and flexible genomic analysis, supporting clinical decision-making and improving patient outcomes.
Industries
Nr. of Employees
medium (51-250)
Congenica
Wellcome Genome Campus, Cambridge, CB10 1DR, United Kingdom
Patents
Screening system and method for determining a presence and an assessment score of cell-free DNA fragments
US-11869630-B2
View Details
Screening system and method for determining a presence and an assessment score of cell-free DNA fragments
US-11869630-B2
View DetailsProducts
Unified genomic analysis platform (inherited disease module)
Modular software for interpretation of inherited and rare genetic disorders, supporting virtual gene panels to whole-genome analysis with curated evidence lists and automated prioritisation.
Prenatal genomics analysis module
Preconfigured analysis for prenatal exome/genome interpretation with curated prenatal gene lists and phenotype-linked evidence to accelerate identification of fetal genetic causes.
Neurodevelopmental disorder analysis module
Module configured to detect and prioritise de novo variants and other variant types associated with neurodevelopmental disorders and early-onset epilepsy.
Precision oncology analysis platform
Automated somatic analysis solution that performs secondary and tertiary interpretation and delivers treatment-matching reports based on regional guidelines and regulatory therapeutic assertions.
Pathogen surveillance analytics platform
Integrated platform for large-scale pathogen sequencing analysis enabling strain/variant identification, outbreak analytics and resistance/response reporting.
Carrier screening service using couple-level modelling
Comprehensive preconception carrier screening that generates a digital couple-level profile to assess offspring carrier risk across autosomal recessive and X-linked inheritance.
Unified genomic analysis platform (inherited disease module)
Modular software for interpretation of inherited and rare genetic disorders, supporting virtual gene panels to whole-genome analysis with curated evidence lists and automated prioritisation.
Prenatal genomics analysis module
Preconfigured analysis for prenatal exome/genome interpretation with curated prenatal gene lists and phenotype-linked evidence to accelerate identification of fetal genetic causes.
Neurodevelopmental disorder analysis module
Module configured to detect and prioritise de novo variants and other variant types associated with neurodevelopmental disorders and early-onset epilepsy.
Precision oncology analysis platform
Automated somatic analysis solution that performs secondary and tertiary interpretation and delivers treatment-matching reports based on regional guidelines and regulatory therapeutic assertions.
Pathogen surveillance analytics platform
Integrated platform for large-scale pathogen sequencing analysis enabling strain/variant identification, outbreak analytics and resistance/response reporting.
Carrier screening service using couple-level modelling
Comprehensive preconception carrier screening that generates a digital couple-level profile to assess offspring carrier risk across autosomal recessive and X-linked inheritance.
Services
End-to-end interpretation support from sequence data or raw reads through variant calling, classification (ACMG-style), and clinical report generation; advisory on lab set-up and assay validation available.
Custom platform integration, configuration and project support to align the analysis platform with customer workflows and IT systems; includes implementation planning and setup.
Dedicated support covering product use, bioinformatics and interpretation; online portal with tutorials, user guides, CNV workflows, learning modules and ticket tracking; guaranteed response within 24 hours.
Bespoke analytics programmes for pharmaceutical customers, including target discovery support, trial analytics and post-market assessment services.
End-to-end interpretation support from sequence data or raw reads through variant calling, classification (ACMG-style), and clinical report generation; advisory on lab set-up and assay validation available.
Custom platform integration, configuration and project support to align the analysis platform with customer workflows and IT systems; includes implementation planning and setup.
Dedicated support covering product use, bioinformatics and interpretation; online portal with tutorials, user guides, CNV workflows, learning modules and ticket tracking; guaranteed response within 24 hours.
Bespoke analytics programmes for pharmaceutical customers, including target discovery support, trial analytics and post-market assessment services.
Expertise Areas
- Clinical variant interpretation and reporting
- Genomic data analysis at population/national scale
- Precision oncology interpretation and treatment matching
- Pathogen genomics and surveillance
Key Technologies
- Next-generation sequencing (NGS)
- Machine learning / AI-driven variant prioritisation
- Cloud and on-premise deployment models (SaaS)
- APIs for LIMS and EHR integration